E

ESBATech, a Novartis company

15 employees

ESBATech develops fully human antibody fragments for therapeutic applications, applying the single-chain antibody framework.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Antibody fragments for therapeutic applications and Ophthalmology
Therapeutics

Date founded

1998

Funding rounds raised

Total raised

$41M

from 7 investors over 7 rounds

E

ESBATech, a Novartis company raised $22M on August 7, 2008

Investors: VI Partners AG, BioMedPartners and Clarus Ventures, LLC

E

ESBATech, a Novartis company raised $41M on August 2, 2006

Investors: VI Partners AG, Clarus Ventures, LLC and BioMedPartners

E

ESBATech, a Novartis company raised $9M on May 14, 2002

Investors: INNOVENTURES CAPITAL MANAGEMENT, INC.

FAQ